Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range ...

KL-6 also predicted SSc-PPF in a 2024 published analysis of patients in the Scleroderma Lung Study II receiving either mycophenolate mofetil (MMF) or cyclophosphamide (CYC) for SSc-ILD ...

It is characterized by generalized skeletal muscle fluctuating weakness and fatigue ... Particularly for Patient 1, the sequential development of aGVHD and cGVHD, accompanied by scleroderma-like skin ...